Current systemic therapies for psoriasis: Where are we now?

被引:44
作者
Yamauchi, PS
Rizk, D
Kormeili, T
Patnaik, R
Lowe, NJ
机构
[1] Clin Res Specialists, Santa Monica, CA 90404 USA
[2] Univ Calif Los Angeles, Sch Med, Div Dermatol, Los Angeles, CA 90024 USA
关键词
D O I
10.1016/mjd.2003.550
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
Many systemic agents are used. in the treatment of psoriasis. They provide good control of psoriasis in the majority of patients and have improved their life quality indices. Frequently, combination therapy is utilized to synergize the efficacy of these medications. Many dermatologists are hesitant in prescribing systemic agents because of their adverse effects. However, such potential toxicities arising from these medications can largely be avoided if proper patient selection and close monitoring are performed.
引用
收藏
页码:S66 / S77
页数:12
相关论文
共 81 条
[1]
Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis [J].
Ameen, M ;
Smith, HR ;
Barker, JNWN .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2001, 26 (06) :480-483
[2]
[Anonymous], 1996, Arch Dermatol, V132, P419
[3]
Combination regimens of topical calcipotriene in chronic plaque psoriasis - Systematic review of efficacy and tolerability [J].
Ashcroft, DM ;
Po, ALW ;
Williams, HC ;
Griffiths, CEM .
ARCHIVES OF DERMATOLOGY, 2000, 136 (12) :1536-1543
[4]
Treatment of psoriasis with intermittent short course cyclosporin (Neoral(R)). A multicentre study [J].
BerthJones, J ;
Henderson, CA ;
Munro, CS ;
Rogers, S ;
Chalmers, RJG ;
Boffa, MJ ;
Norris, PG ;
Friedmann, PS ;
GrahamBrown, RAC ;
Dowd, PM ;
Marks, R ;
Sumner, MJ .
BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (04) :527-530
[5]
Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients [J].
Boffa, MJ ;
Smith, A ;
Chalmers, RJG ;
Mitchell, DM ;
Rowan, B ;
Warnes, TW ;
Shomaf, M ;
Haboubi, NY .
BRITISH JOURNAL OF DERMATOLOGY, 1996, 135 (04) :538-544
[6]
HYDROXYUREA THERAPY [J].
BOYD, AS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 25 (03) :518-524
[7]
Clark CM, 1999, BRIT J DERMATOL, V141, P279
[9]
TREATMENT OF PSORIASIS WITH FOLIC ACID ANTAGONISTS [J].
EDMUNDSON, WF ;
GUY, WB .
ARCHIVES OF DERMATOLOGY, 1958, 78 (02) :200-203
[10]
Troglitazone improves psoriasis and normalizes models of proliferative skin disease -: Ligands for peroxisome proliferator-activated receptor-γ inhibit keratinocyte proliferation [J].
Ellis, CN ;
Varani, J ;
Fisher, GJ ;
Zeigler, ME ;
Pershadsingh, HA ;
Benson, SC ;
Chi, YQ ;
Kurtz, TW .
ARCHIVES OF DERMATOLOGY, 2000, 136 (05) :609-616